Skip to main content
. 2022 Jun 8;11(2):41. doi: 10.3390/antib11020041

Figure 2.

Figure 2

Flow cytometry of EpCAM expressing cells using recEpMab-37. CHO/EpCAM (A), CHO-K1 (B), Caco-2 (C), and BINDS-16 (EpCAM-knocked out Caco-2) (D) cells were treated with 0.01–10 µg/mL of recEpMab-37, followed by treatment with Alexa Fluor 488-conjugated anti-mouse IgG. Black line represents the negative control.